Please assess the completion status of the following clinical trial:

Trial Title: A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Body Mass Index (BMI) \>= 30 and \< 50~* BMI \>= 27 and \< 50 if patient has controlled hypertension or abnormal blood lipids~* Stable weight~* Female patients must be postmenopausal for at least 1 year, surgically incapable of childbearing, practicing abstinence, or practicing an acceptable method of contraception (requires negative pregnancy test)~Exclusion Criteria:~* Known contraindication, or hypersensitivity to topiramate~* A diagnosis of diabetes (except those diagnosed during the enrollment if no medications are needed)~* History or evidence of clinically significant liver, disease, cardiovascular disease, uncontrolled hypertension or high thyroid levels~* History of obesity with known cause~* History of weight loss surgery or liposuction~* History of malignancy within last 5 years

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).